A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis

被引:1
作者
Solanki, Rushil [1 ]
Sreesh, Srijaya [1 ]
Attumalil, Thomas Varghese [2 ]
Mohapatra, Shivabrata dhal [1 ]
Narayanan, Vijay [1 ]
Madhu, Devika [1 ]
Chakravorty, Avisek [1 ]
Pal, Ravindra [1 ]
Nair, Anjana Nalina Kumari kesavan [3 ]
Devadas, Krishnadas [1 ]
机构
[1] Govt Med Coll, Dept Gastroenterol, Thiruvananthapuram, Kerala, India
[2] CMC Vellore, Dept Cardiol, Vellore, India
[3] Govt Med Coll, Dept Community Med, Thiruvananthapuram, Kerala, India
来源
ANNALS OF GASTROENTEROLOGY | 2023年 / 36卷 / 06期
关键词
Left ventricular diastolic dysfunction; cirrhosis; survival; cardiomyopathy; predictors; SURVIVAL; ECHOCARDIOGRAPHY; PREVALENCE; SOCIETY;
D O I
10.20524/aog.2023.0837
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cirrhotic cardiomyopathy. Few studies have addressed its clinical significance in cirrhosis. We assessed the association of LVDD with the factors affecting cirrhosis patients' severity, complications, and survival.Methods A total of 203 cirrhosis patients were enrolled and underwent investigations, including 2-dimensional echocardiography with tissue Doppler imaging, and 139 patients with LVDD (cases) were compared with 64 patients without LVDD (controls). Logistic regression and Kaplan Meier analysis were applied.Results Mean age was 52.76 +/- 10 years. Among LVDD patients, 56% had grade-1, and 44% had grade-2 LVDD. Cirrhosis related to NASH had a more significant association with LVDD (P<0.001) than other etiologies. LVDD was significantly associated with a greater incidence of Child-Turcotte-Pugh (CTP) class C (P<0.001), higher model for end-stage liver disease scores (P=0.001), duration of cirrhosis >2 years since diagnosis (P=0.028), ascites (P<0.001), hepatic encephalopathy (P<0.010), hepatorenal syndrome (P<0.001), and a history of obesity (P=0.004). Multivariate analysis showed that higher CTP score, ascitic fluid protein and prolonged QTc interval were independently associated with LVDD (P=0.009; P=0.018; P=0.016, respectively). Kaplan-Meier survival analysis showed significantly poorer survival status in patients with higher grades of LVDD (P<0.001). The area under the receiver operating characteristic curve (0.78) was greatest for ascitic fluid protein in predicting LVDD, with a cutoff of >1 g/dL. Conclusions Higher CTP score, prolonged QTc, higher ascitic fluid protein levels, and poor survival are significantly associated with LVDD. Ascitic fluid protein >1 g/dL could be an indicator for evaluating LVDD.
引用
收藏
页码:678 / 685
页数:8
相关论文
共 30 条
  • [1] Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis
    Behera, Manas Kumar
    Swain, Surendra Nath
    Sahu, Manoj Kumar
    Behera, Gaurav Kumar
    Mishra, Debakanta
    Narayan, Jimmy
    Singh, Ayaskant
    Agarwal, Shobhit
    Mallick, Pradeep Kumar
    [J]. INTERNATIONAL JOURNAL OF HEPATOLOGY, 2021, 2021
  • [2] Bhuin S, 2017, J EVOL MED DENT SCI-, V6, P5200, DOI 10.14260/jemds/2017/1130
  • [3] Cirrhotic cardiomyopathy: review of pathophysiology and treatment
    Chayanupatkul, Maneerat
    Liangpunsakul, Suthat
    [J]. HEPATOLOGY INTERNATIONAL, 2014, 8 (03) : 308 - 315
  • [4] Dadhich S, 2014, ANN GASTROENTEROL, V27, P244
  • [5] Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients: Prevalence and its possible relationship with clinical outcome
    Falletta, Calogero
    Fili, Daniela
    Nugara, Cinzia
    Di Gesaro, Gabriele
    Mina, Chiara
    Baravoglia, Cesar Mario Hernandez
    Romano, Giuseppe
    Scardulla, Cesare
    Tuzzolino, Fabio
    Vizzini, Giovanni
    Clemenza, Francesco
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (10) : 830 - 834
  • [6] Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
    Francque, Sven M.
    van der Graaff, Denise
    Kwanten, Wilhelmus J.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 425 - 443
  • [7] The changing role of beta-blocker therapy in patients with cirrhosis
    Ge, Phillip S.
    Runyon, Bruce A.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (03) : 643 - 653
  • [8] Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?
    Hammami, Rania
    Boudabbous, Mouna
    Jdidi, Jihen
    Trabelsi, Fatma
    Mroua, Fakher
    Kallel, Rahma
    Amouri, Ali
    Abid, Dorra
    Tahri, Nabil
    Abid, Leila
    Kammoun, Samir
    [J]. LIBYAN JOURNAL OF MEDICINE, 2017, 12
  • [9] The clinical course of cirrhosis: The importance of multistate models and competing risks analysis
    Jepsen, Peter
    Vilstrup, Hendrik
    Andersen, Per Kragh
    [J]. HEPATOLOGY, 2015, 62 (01) : 292 - 302
  • [10] Recent Advances in Cirrhotic Cardiomyopathy
    Karagiannakis, Dimitrios S.
    Papatheodoridis, George
    Vlachogiannakos, Jiannis
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (05) : 1141 - 1151